Climb Bio Inc
CLYM
NASDAQ
Biotechnology
$16.33
USD
+1.60 (+10.86%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $846.04M
Volume 2.5M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
ODTX | Odyssey Therapeutics Inc | $1.07B | - | -19.0% | - | |
GERN | Geron Corp | $1.01B | - | +24.4% | - | |
JANX | Janux Therapeutics Inc | $978.19M | - | +5367.0% | - | |
OLMA | Olema Pharmaceuticals Inc | $919.60M | - | - | - | |
KURA | Kura Oncology Inc | $915.26M | - | - | - | |
DSGN | Design Therapeutics Inc | $900.55M | - | - | - | |
CADL | Candel Therapeutics Inc | $864.59M | - | - | - | |
ANNX | Annexon Inc | $856.08M | - | - | - | |
CLYM | Climb Bio Inc | $846.04M | - | - | - | |
FTH | Faeth Therapeutics, Inc | $737.74M | - | - | - |
Top Peer by Growth
Janux Therapeutics Inc
+5367.0% YoY Revenue
Best 1-Year Return
Climb Bio Inc
+793.8% Return